News | News By Subject | News by Disease News By Date | Search News

Post-Approval (World) News

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
AstraZeneca PLC (AZN)'s Diabetes Drug Onglyza May Increase Risk of Heart Failure, FDA Panel Reports     4/13/2015
AstraZeneca PLC (AZN)'s Brilinta Proves Worthy Despite Higher Bleeding Risk     3/16/2015
Novartis AG (NVS) May Already Have First True Anti-Aging Drug in Its Pipeline     2/19/2015
New Study Vindicates Efficacy of Roche (RHHBY)'s Blockbuster Drug Tamiflu     2/2/2015
Roche (RHHBY) Suffers A Double Blow As Breast Cancer, Alzheimer’s Drug Studies Fail; Pulls Plug On ALZ's Drug Development     12/23/2014
National Institute for Clinical Excellence (NICE) Requests More Info On Novartis AG (NVS)'s Xolair To Treat Chronic Hives     11/20/2014
AstraZeneca PLC (AZN)'s New Drug Olaparib May Also Work In Prostate Cancer     11/5/2014
Roche (RHHBY), Merck & Co. (MRK) Extend Immunotherapy Battle To Breast Cancer     10/17/2014
Study Shows Novo Nordisk A/S (NVO)'s New Diabetes Drug Tresiba Effective And Safe For Children     9/16/2014
Novartis AG (NVS): Rate Of Brain Shrinkage Faster In Multiple Schlerosis Patients     9/10/2014
Amgen (AMGN), Servier Heart Drug Runs Into Safety Concerns In Major Clinical Study     9/4/2014
Sanofi Pasteur (SASY.PA) Touts Positive Trial Data For Fluzone High-Dose Vaccine     8/14/2014
Scientists Retract Narcolepsy Study Linked To GlaxoSmithKline (GSK) Flu Vaccine     8/11/2014
Study Claims Celgene (CELG) Drug Can Drive HIV Out Of Hiding     7/25/2014
Shire Reports Results From Two Head-To-Head Studies Comparing Vyvanse® With Concerta® In ADHD Study     7/18/2014

Featured Stories
Roche (RHHBY) Scientists Testing to See if Arthritis Blockbuster Will Work for Diabetes     4/10/2015
EXCLUSIVE: NHS Uses Ineffective IPF Therapy     12/5/2014
Ibuprofen No Good in Treating Colds or Sore Throats, University of Southampton Study     11/5/2013
Ticagrelor Does Not Affect Pulmonary Function in ACS Patients, University of Sheffield Study     10/14/2011
Old Osteoporosis Drug May Help In Killing Flu Viruses, University of Hong Kong Study     6/29/2011
One in Five Heart Attack Deaths Could be Prevented with New Drug, University of Sheffield Study     6/14/2011
Viagra Could Reduce Multiple Sclerosis Symptoms, Autonoma de Barcelona Study     5/20/2011
Renal Cancer Drug Temsirolimus Shows Promise Against Mesothelioma, Medical University of Vienna Study     5/2/2011
Diabetes Treatment May Also Provide Protection Against Endometrial Cancer, University of Warwick and Warwick Medical School Study     4/6/2011
Infectious Diseases Society of America: Linezolid Wins Battle on MRSA Pneumonia, Pitie-Salpetriere Hospital Study     10/27/2010
Boehringer Ingelheim Corporation, Pfizer Inc. (PFE)'s Spiriva Improves Asthma Treatment, Study Shows     9/22/2010
Common Pain Relievers Raise Heart Risk for Healthy Folks, Gentofte University Hospital Study     6/9/2010
Common Cholesterol Drugs, Statins, Fight Cataracts, Too, Tel Aviv University Study     2/12/2010
Switching Immunosuppressants Reduces Cancer Risk In Kidney, Queen Elizabeth Hospital Study     11/2/2009
Combination Antiretroviral Therapy Effective At Reducing HIV Resistance In Mothers And Babies Following Mother-to-child Transmission, Study Funded by Boehringer Ingelheim Corporation     10/28/2009
Boehringer Ingelheim Release: First Patient Enrolled In Dabigatran Study Comparing Anticoagulation Strategies During AF Ablation     5/13/2015
Teva (TEVA) Presents Data Comparing Early Treatment With COPAXONE 40 Mg/Ml To Delayed Start Treatment At 67th American Academy of Neurology Annual Meeting In Washington, D.C.     4/23/2015
Hemispherx Biopharma Europe N.V./S.A. Receives Positive Opinion On Application For Orphan Designation By The European Medicines Agency Agency For Ampligen To Treat Patients With Ebola Virus Disease (EVD)     3/24/2015
Boehringer Ingelheim Release: Many Atrial Fibrillation Patients At High Risk Of Stroke Fail To Receive Guideline-Recommended Oral Anticoagulant Treatment     3/16/2015
Celltrion Healthcare: Data Show The World’s First European Medicines Agency-Approved Biosimilar Monoclonal Antibody Remsima Could Reduce Cost Of Treating Crohn’s Disease By Up To €336 Million Over Five Years     2/20/2015
DBV Technologies Announces Publication In The Journal Of Allergy And Clinical Immunology Of Data Demonstrating That Epicutaneous Immunotherapy May Influence The Natural History Of Allergy     1/12/2015
Genentech (RHHBY) Provides Update On Phase 3 MARIANNE Study In People With Previously Untreated Advanced HER2-Positive Breast Cancer     12/19/2014
Teva Pharmaceutical Industries Limited (TEVA) Presents Positive Safety And Efficacy Data For QNASL® (Beclomethasone Dipropionate) Nasal Aerosol In Treating Children With Perennial Allergic Rhinitis     11/7/2014
Changing The Way We Combat Bacterial Infections: Dutch Biotech Micreos Launches First Bacteria-Killing Enzyme For Human Use Against MRSA     11/5/2014
Teva Pharmaceutical Industries Limited (TEVA) And Active Biotech AB (BTPC) Announce Expansion Of Laquinimod Clinical Development Program With New Trial In Primary Progressive Multiple Sclerosis And First Patient Screened In Huntington’s Disease Trial     11/4/2014
Otsuka America Pharmaceutical, Inc. And H. Lundbeck A/S (LUN.CO) Release: Aripiprazole Once-Monthly Injectable Shows Superior Effectiveness To Paliperidone Palmitate Once-Monthly Injectable On Quality Of Life Scale In Patients With Schizophrenia     11/3/2014
Boehringer Ingelheim GmbH Release: FDA Medicare Study In 134,000 Atrial Fibrillation Patients Confirms Positive Safety Profile And Effectiveness Of Pradaxa® In General Practice     11/3/2014
Celgene International Sárl (CELG) Release: New Analyses Of Oral OTEZLA® (Apremilast) Presented At EADV Show Efficacy In Difficult-To-Treat Areas Of Moderate To Severe Plaque Psoriasis     10/10/2014
Celgene International Sárl (CELG) Release: Oral OTEZLA® (Apremilast) Data Presented At EADV Show Improved Measures Of Health-Related Quality Of Life And Work Productivity In Patients With Moderate To Severe Plaque Psoriasis     10/10/2014
Celgene International Sárl (CELG) To Present Long-Term Efficacy And Safety Data On Oral OTEZLA® (Apremilast) In Plaque Psoriasis And Psoriatic Arthritis At European Academy Of Dermatology And Venereology Congress     10/7/2014

More News
No News Posted on that date

Career Tips
HR Exec Says Alder Biopharma Will Grow 30% in 2015, As Hunt for Candidates Continues     5/15/2015
The After-Interview Trick You’re Not Using     5/14/2015
New Networking Opportunities at Talent Connect, Over 600 Bioscience Jobs Available Now     5/14/2015
THERAVECTYS Upped Hiring Almost Five-Fold in 2014, As Biotech Booms, Says HR Head     5/1/2015
4 Phrases You’ll Need at Your Next Networking Event     4/30/2015
Avoid a Job Mismatch     4/30/2015
Sucampo (SCMP) Looks to Add to "Scientific Core" As Global Reach Grows, Says HR     4/16/2015
8 Things That are Hurting Your Resume     4/16/2015
8 Ways to Increase Your Paycheck     4/16/2015
Flexion (FLXN) CEO Discusses Pipeline and Jobs     4/3/2015
What Employers Think When They See Your LinkedIn Profile     4/2/2015
Five Ways to Build Rapport With Your Interviewer     4/2/2015
Relypsa (RLYP) Hits the Big Leagues: New Hires in Almost Every Department     3/19/2015
Four Common Job Applicant Weaknesses     3/19/2015
Three Resume Secrets Professionals Swear By     3/19/2015

Other News Sources
//-->